Maxim Group Reiterates “Buy” Rating for Kazia Therapeutics (NASDAQ:KZIA)
Kazia Therapeutics (NASDAQ:KZIA – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Maxim Group in a report released on Wednesday,Benzinga reports. They currently have a $15.00 target price on the stock. Maxim Group’s target price points to a potential upside of 53.22% from the company’s current price. Kazia Therapeutics Trading […]
Kazia Therapeutics (NASDAQ:KZIA – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Maxim Group in a report released on Wednesday,Benzinga reports. They currently have a $15.00 target price on the stock. Maxim Group’s target price points to a potential upside of 53.22% from the company’s current price. Kazia Therapeutics Trading […]
